Skip to main content

Advertisement

SpringerLink
Log in

Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

We investigated trends over a decade in the prescription of lithium, antiepileptics, and antipsychotic agents at discharge for patients hospitalised for acute mania. We conducted a retrospective review of medical records for 165 inpatients with acute mania who had been hospitalised in Cerrahpaşa Faculty of Medicine, Department of Psychiatry during 2001–2002 and 2011–2012. Among 165 patients, prescription of olanzapine at discharge increased from 3 to 46 % (p < 0.001), while prescription of haloperidol decreased from 55 to 21 % (p < 0.001). Use of other atypical antipsychotics did not change significantly (risperidone decreased from 14 to 11 %, p = 0.5; quetiapine increased from 10 to 16 %, p = 0.2). Use of valproate, carbamazepine, and lithium did not change significantly. Use of electroconvulsive therapy in acute mania decreased by half from 27 to 13 % (p = 0.02). Typical antipsychotics alone or in combination with antiepileptics were the most common treatment regimen at discharge at 2001–2002; while 10 years later, they had been largely replaced by lithium or antiepileptics combined with second generation antipsychotics. Antipsychotic agents remained to be an important component of acute treatment of mania in our practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Angst J, Sellaro R: Historical perspectives and natural history of bipolar disorder. Biological Psychiatry 48:445–57, 2000.

    Article  CAS  PubMed  Google Scholar 

  2. Baldessarini RJ: Treatment research in bipolar disorder: issues and recommendations. CNS Drugs 16:721–9, 2002.

    Article  PubMed  Google Scholar 

  3. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J: Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatric Services 58:85–91, 2007.

    Article  PubMed  Google Scholar 

  4. Berk M, Ichim L, Brook S: Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. International Clinical Psychopharmacology 14:339–343, 1999.

    Article  CAS  PubMed  Google Scholar 

  5. Bonnin CM, Martinez-Aran A, Torrent C, Pacchiarotti I, Rosa AR, Franco C, Murru A, Sanchez-Moreno J, Vieta E: Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. Journal of Affective Disorders 121:156–160, 2010.

    Article  CAS  PubMed  Google Scholar 

  6. Buoli M, Serati M, Altamura AC: Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. Journal of Affective Disorders 152–154:12–18, 2014.

    Article  PubMed  Google Scholar 

  7. Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoyR, WilsonE, Mullen J: A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry 162:1351–1360, 2005.

    Article  PubMed  Google Scholar 

  8. Centorrino F, Ventriglio A, Vincenti A, Talamo A, Baldessarini RJ: Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Human Psychopharmacology 25:179–186, 2010.

    Article  PubMed  Google Scholar 

  9. Cipriani A, Barbui C, Salanti G, Rendell J, Brown R, Stockton S, Purgato M, Spineli LM, Goodwin GM, Geddes JR: Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet 378:1306–15, 2011.

    Article  CAS  PubMed  Google Scholar 

  10. Cipriani A, Rendell J, Geddes JR: Olanzapine in the long-term treatment of bipolar disorder: a systematic review and meta-analysis. Journal of Psychopharmacology 24:1729–1738, 2010.

    Article  CAS  PubMed  Google Scholar 

  11. Geddes JR, Miklowitz DJ: Treatment of bipolar disorder. Lancet 381:1672–1682, 2013.

    Article  CAS  PubMed  Google Scholar 

  12. Ghaemi SN, Katzow JJ: The use of quetiapine for treatment-resistant bipolar disorder: a case series. Annals of Clinical Psychiatry 11:137–140, 1999.

    Article  CAS  PubMed  Google Scholar 

  13. Goikolea JM, Colom F, Torres I, Capapey J, Valenti M, Undurraga J, Grande I, Sanchez-Moreno J, Vieta E: Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Journal of Affective Disorders 144:191–198, 2013.

    Article  CAS  PubMed  Google Scholar 

  14. Goodwin FK: Manic-depressive illness. Oxford University Press, New York, 1990.

    Google Scholar 

  15. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D: Suicide risk in bipolar disorder during treatment with lithium and divalproex. Journal of the American Medical Association 290:1467–1473, 2003.

    Article  CAS  PubMed  Google Scholar 

  16. Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R: A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. Journal of Clinical Psychiatry 65:432–41, 2004.

    Article  CAS  PubMed  Google Scholar 

  17. Goodwin GM; Consensus Group of the British Association for Psychopharmacology: Evidence-based guidelines for treating bipolar disorder: revised second edition—recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 23:346–88, 2009.

    Article  Google Scholar 

  18. Greil W, Haberle A, Haueis P, Grohmann R, Russmann S: Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. Journal of Affective Disorders 136:534–42, 2012.

    Article  PubMed  Google Scholar 

  19. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S.: The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World Journal of Biological Psychiatry 10:85–116, 2009.

    Article  PubMed  Google Scholar 

  20. Harris EC, Barraclough B: Suicide as an outcome for mental disorders. A meta-analysis. British Journal of Psychiatry 170:205–228, 1997.

    Article  CAS  PubMed  Google Scholar 

  21. Hayes J, Prah P, Nazareth I, King M, Walters K, Petersen I, Osborn D: Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PLoS ONE 6:e28725, 2011.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hooshmand F., Miller S, Dore J, Wang PW, Hill SJ, Portillo N, Ketter TA: Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000-2011. Journal of Affective Disorders 155:283–287, 2014.

    Article  CAS  PubMed  Google Scholar 

  23. Malempati RN: Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study. Journal of Nervous and Mental Disease 203:58–64, 2015.

    Article  PubMed  Google Scholar 

  24. McElroy SL, Keck PE Jr: Pharmacologic agents for the treatment of acute bipolar mania. Biological Psychiatry 48:539–57, 2000.

    Article  CAS  PubMed  Google Scholar 

  25. Medda P, Toni C, Perugi G: The mood-stabilizing effects of electroconvulsive therapy. Journal of ECT 30:275–82, 2014.

    Article  CAS  PubMed  Google Scholar 

  26. Mohammad O, Osser DN: The psychopharmacology algorithm project at the Harvard South Shore Program: an algorithm for acute mania. Harvard Review of Psychiatry 22:274–294, 2014.

    Article  PubMed  Google Scholar 

  27. Mukherjee S, Sackeim HA, Schnur DB: Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. The American Journal of Psychiatry 151:169–176, 1994.

    Article  CAS  PubMed  Google Scholar 

  28. Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Furukawa TA: Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. CNS Drugs 28: 989–1003, 2014.

    Article  CAS  PubMed  Google Scholar 

  29. Segal J, Berk M, Brook S: Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology 21:176–180, 1998.

    CAS  PubMed  Google Scholar 

  30. Sernyak MJ, Griffin RA, Johnson RM, Pearsall HR, Wexler BE, Woods SW: Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. American Journal of Psychiatry 151:133–135, 1994.

    Article  CAS  PubMed  Google Scholar 

  31. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D: Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. Acta Psychiatrica Scandinavica 115:12–20, 2007.

    Article  CAS  PubMed  Google Scholar 

  32. Srivastava S, Ketter TA, Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects. Clinical Therapeutics 33:B40–B48, 2011.

    Article  PubMed  Google Scholar 

  33. Walpoth-Niederwanger M, Kemmler G, Grunze H, Weiss U, Hortnagl C, Strauss R, Blasko I, Hausmann A: Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers. International Clinical Psychopharmacology 27:256–266, 2012.

    Article  PubMed  Google Scholar 

  34. Wang Z, Gao K, Hong W, Xing M, Wu Z, Chen J, Zhang C, Yuan C, Huang J, Peng D, Wang Y, Lu W, Yi Z, Yu X, Zhao J, Fang Y: Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China. BMC Psychiatry 14:167, 2014.

    Article  PubMed  PubMed Central  Google Scholar 

  35. WHO: The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, World Health Organization, 1992.

    Google Scholar 

  36. Wolfsperger M, Greil W, Rossler W, Grohmann R: Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. Journal of Affective Disorders 99:9–17, 2007.

    Article  PubMed  Google Scholar 

  37. Yang M, Barner JC, Lawson KA, Rascati KL, Wilson JP, Crismon ML, Worchel J, Mascarenas CA: Antipsychotic medication utilization trends among Texas veterans: 1997-2002. Annals of Pharmacotherapy 42:1229–1238, 2008.

    Article  PubMed  Google Scholar 

  38. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, O’Donovan C, Macqueen G, McIntyre RS, Sharma V, Ravindran A, Young LT, Milev R, Bond DJ, Frey BN, Goldstein BI, Lafer B, Birmaher B, Ha K, Nolen, WA, Berk M: Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorder 15:1–44, 2013.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research received no specific grants from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Psychiatry, Cerrahpaşa Faculty of Medicine, Cerrahpaşa Medical School, Istanbul University, Halaskargazi c. No:81 Çiçek apt. daire:8, Istanbul, Turkey

    Mehmet Kemal Arıkan, Cana Aksoy Poyraz, Alper Baş, N. Gamze Usta Sağlam, Gizem Cetiner Batun, Gözde Gültekin & Burç Çağrı Poyraz

Authors
  1. Mehmet Kemal Arıkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cana Aksoy Poyraz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alper Baş
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Gamze Usta Sağlam
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gizem Cetiner Batun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gözde Gültekin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Burç Çağrı Poyraz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cana Aksoy Poyraz.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arıkan, M.K., Poyraz, C.A., Baş, A. et al. Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade. Psychiatr Q 87, 305–313 (2016). https://doi.org/10.1007/s11126-015-9388-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-015-9388-9

Keywords

Search

Navigation